IL-33 is an important endogenous regulator in stroke, which can downregulate the level of pro-inflammatory cytokines, inhibit apoptosis and autophagy, and exert anti-inflammatory effects on brain edema caused by ICH [167]. This evidence concerns the gene IL33 and Stroke.